Description

DSP Finance Private Limited has listed commercial paper worth Rs. 100 crore on BSE Debt segment with ICRA A1+ rating, maturing on March 13, 2026.

Summary

DSP Finance Private Limited has listed new commercial paper instruments on BSE’s Debt segment with effect from December 16, 2025. The issue comprises 2,000 units of Rs. 5 lakh each, totaling Rs. 100 crore, issued on private placement basis. The instruments carry an ICRA A1+ credit rating and will mature on March 13, 2026. ICICI Bank Limited serves as the issuing and paying agent.

Key Points

  • Scrip Code: 730778, Scrip ID: DFPL151225
  • ISIN Number: INE422H14164
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,91,876.50 per unit
  • Total Quantity: 2,000 units (Rs. 100 crore)
  • Market Lot: 1 unit
  • Credit Rating: ICRA A1+
  • Trading denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise
  • Trading only in dematerialized form

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for debt instruments.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE422H14164
  • Trading must be conducted in standard denomination of Rs. 5 lakhs and multiples thereof
  • Members requiring clarification may contact BSE debt department on specified phone numbers (22728352/8597/8995/5753/8915)

Important Dates

  • Date of Allotment: December 15, 2025
  • Listing Date: December 16, 2025
  • Redemption Date: March 13, 2026
  • Notice Date: December 16, 2025

Impact Assessment

This is a routine commercial paper listing with minimal market impact. The listing provides short-term debt market participants with an additional ICRA A1+ rated instrument for a 88-day tenure. As this is a private placement in the debt segment, there is no impact on equity markets or broader trading operations. The instrument offers institutional investors a short-term investment option from DSP Finance Private Limited.

Impact Justification

Routine commercial paper listing with no impact on equity markets or regulatory changes